Pancreatic Cancer Research

ResearcherYamaguchi UniversityNo recent work listed

Yuko Fujimoto

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112076197. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

  1. CA19-9 in Combination with Methylated HOXA1 and SST Is Useful to Diagnose Stage I Pancreatic Cancer. Co-author DOI 10.1159/000527342↗
  2. Combination of CA19-9 and Blood Free-Circulating Methylated RUNX3 May Be Useful to Diagnose Stage I Pancreatic Cancer. Co-author DOI 10.1159/000511940↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Taro Takami · 2 shared papers, 2021–2022 · strength 0.23
  2. Isao Sakaida · 2 shared papers, 2021–2022 · strength 0.23
  3. Yutaka Suehiro · 2 shared papers, 2021–2022 · strength 0.23
  4. Takahiro Yamasaki · 2 shared papers, 2021–2022 · strength 0.23
  5. Hiroto Matsui · 2 shared papers, 2021–2022 · strength 0.23
  6. Shigeyuki Suenaga · 2 shared papers, 2021–2022 · strength 0.23
  7. Kaori Hamamoto · 1 shared paper, 2022 · strength 0.12
  8. Shogo Amano · 1 shared paper, 2022 · strength 0.12
  9. Hiroaki Nagano · 1 shared paper, 2022 · strength 0.12
  10. Keiko Shinjo · 1 shared paper, 2022 · strength 0.12
  11. Yutaka Kondo · 1 shared paper, 2022 · strength 0.12
  12. Hiroaki Nagano · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.